Skip to content

Clinical trials

Phase 2 Gliosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gliosarcoma Phase: Phase 2 Country / region: United States Clear all

162 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200110
20026
20036
20047
200512
200612
200716
200813
200911
201010
20113
20125
20136
20141
20154
20161
20172
20182
20193
20211
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed117
Terminated26
Unknown status9
Active, not recruiting5
Withdrawn3
Suspended1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)30
Duke University21
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins11
Radiation Therapy Oncology Group5
University of California, San Francisco5
Alliance for Clinical Trials in Oncology4
Jonsson Comprehensive Cancer Center4
Memorial Sloan Kettering Cancer Center4
Northwestern University4
Case Comprehensive Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gliosarcoma162
Glioblastoma160
Brain Neoplasms88
Central Nervous System Neoplasms68
Astrocytoma55
Glioma55
Oligodendroglioma39
Ependymoma12
Glioma, Subependymal8
Medulloblastoma5

Trials

Showing 1 to 25 of 162. Each trial links to its page on Pharma Observatory.

62 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.